Glenmark said Ryaltris is now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age.from Moneycontrol Business News https://ift.tt/3dTwj0W
Glenmark said Ryaltris is now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age.
Comments
Post a Comment